Clinical trial · Interventional
Recombinant Versus Highly Purified FSH in Polycystic Ovary Syndrome (PCOS)
Recombinant FSH Versus Highly Purified FSH in PCOS Patients Undergoing Control Ovarian Stimulation and IVF: a Prospective Randomized Study
NCT01337531CI-TRIAL-00004700unknownPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Control ovarian stimulation responses, pregnancy and miscarriage rates are indifferent when either recombinant or highly purified follicle stimulating hormone (FSH) is used.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Polycystic Ovary Syndrome | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Gonal-F, Fostimon | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- gonadotropin
- description
- recombinant or highly purified gonadotropin
- interventionNames
- Drug: Gonal-F, Fostimon
- type
- ACTIVE_COMPARATOR
- label
- Gonadotropins
- description
- recombinant versus highly purified gonadotropin
- interventionNames
- Drug: Gonal-F, Fostimon
Primary outcomes (1)
- measure
- Ovarian Response
- timeFrame
- 0-15 days post gonadotropin administration
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
- Maximum age
- 40 Years
Show eligibility criteria text
Inclusion Criteria: * PCOS * Primary infertility * No other fertility manifestation Exclusion Criteria: * Non PCOS * Secondary infertility
References
Publications (0)
Data not yet available
No reference posted for this study.